Controversy over oseltamivir and its effectiveness against influenza

Authors

  • Humberto Vásquez Cubas Hospital de Emergencias Grau, EsSalud. Lima, Perú

DOI:

https://doi.org/10.15381/anales.802.16420

Abstract

Complications of viral respiratory infections cause significant mortality. During the 2009 H1N1 flu epidemic, 18449 deaths were reported worldwide. In Peru, there were 312 deaths due to H1N1 flu reported by the Ministry of Health. Oseltamivir is still considered essential in severe cases of H1N1 influenza; however there is controversy about their benefit and their safety. The literature is reviewed, which leads us to conclude that rational use and the evaluation of its cost effectiveness are importan

Downloads

Published

2019-06-30

Issue

Vol. 80 No. 2 (2019)

Section

Artículo Especial

License

Copyright (c) 2019 Anales de la Facultad de Medicina

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Those authors who have publications with this magazine accept the following terms:

  1. Authors will retain their copyrights and guarantee the journal the right of first publication of their work, which will be simultaneously subject to Creative Commons Attribution License that allows third parties to share the work as long as its author and its first publication this magazine are indicated.
  2. Authors may adopt other non-exclusive licensing agreements for the distribution of the version of the published work (eg, deposit it in an institutional electronic file or publish it in a monographic volume) provided that the initial publication in this magazine is indicated.
  3. Authors are allowed and recommended to disseminate their work over the Internet (eg: in institutional telematic archives or on their website) before and during the submission process, which It can produce interesting exchanges and increase quotes from the published work. (See El efecto del acceso abierto ).

How to Cite

1.
Vásquez Cubas H. Controversy over oseltamivir and its effectiveness against influenza. An Fac med [Internet]. 2019 Jun. 30 [cited 2024 Aug. 16];80(2):234-8. Available from: https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/16420